Ryan Fukushima | Reinventing diagnostics: The superpower of not knowing what can’t be done | TPM #43

What a pleasure to welcome today’s guest, Ryan Fukushima, chief operating officer of TempusAI. Not only has Ryan helped build Tempus brick by brick from the earliest days, he is also CEO of Pathos AI, a biotech company using real world data and AI to develop true precision medicines. I don’t know how he juggles it all, but unless you’ve been hiding out these last few years, Tempus has become a household name in our industry, completing a highly successful IPO last year. But no need to take my word for it, come on in and have a listen!


TPM E43 highlights >⁠⁠⁠⁠⁠⁠


Episode 43 links:

Ryan Fukushima on LinkedIn⁠

⁠Tempus AI⁠

⁠Pathos⁠

⁠Tempus announces multi-year collaboration with Genialis

Om Podcasten

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.